bf/NASDAQ:ANIK_icon.jpeg

NASDAQ:ANIK

Anika Therapeutics

  • Stock

14.46

−0.48%

5.28

USD last updated 28/08 01:57:18

Last Close

9.18

27/08 20:01

Market Cap

389.26M

Beta: 0.83

Volume Today

45.35K

Avg: 81.01K

PE Ratio

−14.02

PFCF: −31.16

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
Dec '24
revenue
105.59M
-
93.00M
11.93%
103.38M
11.16%
113.42M
9.71%
105.56M
6.93%
114.61M
8.58%
130.46M
13.83%
147.79M
13.29%
156.24M
5.71%
166.66M
6.67%
119.91M
28.05%
cost of revenue
20.93M
-
21.05M
0.59%
24.03M
14.13%
27.36M
13.89%
31.28M
14.31%
28.75M
8.10%
61.43M
113.70%
64.85M
5.57%
62.66M
3.38%
63.57M
1.46%
43.91M
30.93%
gross profit
84.66M
-
71.95M
15.02%
79.35M
10.29%
86.06M
8.45%
74.28M
13.69%
85.86M
15.60%
69.03M
19.61%
82.94M
20.16%
93.58M
12.82%
103.09M
10.16%
76.00M
26.28%
selling and marketing expenses
general and administrative expenses
15.07M
-
14.82M
1.65%
18.01M
21.50%
21.54M
19.58%
34.34M
59.41%
selling general and administrative expenses
15.07M
-
14.82M
1.65%
18.01M
21.50%
21.54M
19.58%
34.34M
59.41%
34.95M
1.79%
60.06M
71.85%
74.10M
23.36%
84.79M
14.44%
95.85M
13.04%
55.55M
42.04%
research and development expenses
8.14M
-
8.99M
10.35%
10.73M
19.42%
18.79M
75.06%
18.19M
3.18%
16.66M
8.38%
23.43M
40.60%
27.33M
16.63%
28.18M
3.13%
32.69M
16.00%
25.54M
21.86%
other expenses
cost and expenses
44.15M
-
44.87M
1.62%
52.77M
17.62%
67.69M
28.27%
83.81M
23.81%
80.36M
4.11%
144.93M
80.34%
166.27M
14.73%
175.64M
5.63%
192.11M
9.38%
125.01M
34.93%
operating expenses
23.22M
-
23.81M
2.56%
28.75M
20.72%
40.33M
40.29%
52.53M
30.25%
51.62M
1.73%
83.49M
61.76%
101.42M
21.47%
112.98M
11.39%
128.54M
13.77%
81.10M
36.91%
interest expense
-58.14K
-
-120K
106.41%
-263K
119.17%
-473K
79.85%
-1.46M
208.25%
-302K
-
-188K
37.75%
654K
447.87%
2.31M
253.52%
ebitda
61.45M
-
48.13M
21.67%
50.61M
5.14%
45.73M
9.64%
21.75M
52.44%
34.25M
57.47%
-614K
101.79%
-39.58M
6,345.44%
-19.40M
50.98%
-11.21M
42.19%
3.02M
126.93%
operating income
61.45M
-
48.13M
21.67%
50.61M
5.14%
45.73M
9.64%
21.75M
52.44%
34.25M
57.47%
-14.47M
142.24%
-18.48M
27.73%
-19.40M
4.98%
-25.45M
31.18%
-5.10M
79.96%
depreciation and amortization
4.71M
-
3.77M
19.78%
3.73M
1.09%
4.29M
14.89%
5.91M
37.76%
5.99M
1.37%
13.85M
131.25%
-21.09M
252.27%
14.49M
168.68%
14.23M
1.75%
8.12M
42.95%
total other income expenses net
58.14K
-
120K
106.41%
263K
119.17%
473K
79.85%
1.46M
208.25%
1.87M
28.46%
-14.16M
855.79%
20.91M
247.69%
654K
96.87%
-59.88M
9,255.66%
2.34M
103.90%
income before tax
61.51M
-
48.25M
21.54%
50.87M
5.42%
46.20M
9.18%
23.21M
49.77%
36.12M
55.65%
-28.62M
179.24%
2.43M
108.48%
-18.75M
872.39%
-85.33M
355.17%
-2.76M
96.76%
income tax expense
23.19M
-
17.50M
24.54%
18.32M
4.73%
14.39M
21.49%
4.49M
68.82%
8.93M
99.06%
-4.64M
151.99%
-1.71M
63.23%
-3.89M
127.71%
-2.66M
31.57%
6.06M
327.97%
net income
38.32M
-
30.76M
19.73%
32.55M
5.82%
31.82M
2.25%
18.72M
41.16%
27.19M
45.25%
-23.98M
188.19%
4.13M
117.24%
-14.86M
459.43%
-82.67M
456.34%
-56.38M
31.79%
weighted average shs out
14.68M
-
14.93M
1.74%
14.68M
1.69%
14.57M
0.73%
14.44M
0.91%
14.12M
2.22%
14.22M
0.72%
14.40M
1.26%
14.56M
1.11%
14.66M
0.65%
14.72M
0.44%
weighted average shs out dil
15.27M
-
15.32M
0.34%
15.12M
1.34%
15.07M
0.32%
14.69M
2.52%
14.37M
2.14%
14.22M
1.06%
14.63M
2.90%
14.56M
0.50%
14.66M
0.65%
14.72M
0.44%
eps
2.61
-
2.06
21.07%
2.22
7.77%
2.18
1.80%
1.30
40.37%
1.93
48.46%
-1.69
187.56%
0.29
117.16%
-1.02
451.72%
-5.64
452.94%
-3.83
32.09%
epsdiluted
2.51
-
2.01
19.92%
2.15
6.97%
2.11
1.86%
1.27
39.81%
1.89
48.82%
-1.69
189.42%
0.28
116.57%
-1.02
464.29%
-5.64
452.94%
-3.83
32.09%

All numbers in USD (except ratios and percentages)